Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

3
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
3
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.6K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

9.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.9K
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

1
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
1
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

273
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
273

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Scales and Wearable Sensors in Patients with Essential Tremor Treated with Deep Brain Stimulation.

Movement disorders clinical practice·2026
Same author

Characterization of a distinct form of vimentin in the neurodegenerative brain.

Acta neuropathologica communications·2026
Same author

Dementia Prediction Using Gait Analysis and Machine Learning.

Studies in health technology and informatics·2026
Same author

Supervised Learning Provides Small but Consistent Improvements to Clustering when Predicting Chronic Pain Outcomes Following Treatment.

Studies in health technology and informatics·2026
Same author

Data-driven clustering of chronic pain profiles using Swedish national registry data: Towards individualized decision support in interdisciplinary rehabilitation.

International journal of medical informatics·2026
Same author

Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2026

Related Experiment Video

Updated: Feb 13, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K

Individual dose-response models for levodopa infusion dose optimization.

Ilias Thomas1, Moudud Alam1, Dag Nyholm2

  • 1Department of Micro-data analysis, Dalarna University, Falun, 79 131, Sweden.

International Journal of Medical Informatics
|March 4, 2018
PubMed
Summary

This study introduces an algorithm to optimize continuous infusion treatment for Parkinson's disease (PD) by creating personalized dose-response models. The method shows promise for assisting clinicians in making informed dose adjustment decisions.

Keywords:
Algorithmic dosing suggestionsLevodopa infusionParkinson’s diseasePatient-specific models

More Related Videos

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.9K

Area of Science:

  • Neurology
  • Pharmacology
  • Medical Informatics

Background:

  • Continuous infusion treatment is vital for managing Parkinson's disease (PD).
  • Optimizing individual doses (morning dose and infusion rate) is crucial for treatment efficacy.
  • Current titration methods rely on trained medical personnel.

Purpose of the Study:

  • To develop and investigate an algorithmic method for optimizing continuous infusion treatment in Parkinson's disease.
  • To derive optimized dosing suggestions by fitting individual dose-response models.
  • To assess the feasibility of the proposed method using patient chart data.

Main Methods:

  • Collected patient records including dosing information and dose-response evaluations from Uppsala University hospital.
  • Employed mathematical optimization techniques to fit individual patient models by minimizing an objective function.
  • Utilized a dose optimization algorithm to generate suggested doses based on fitted individual models.

Main Results:

  • The algorithm effectively fitted individual patient models and derived optimized doses from single-day data.
  • Infusion rate suggestions demonstrated a 0.88 correlation and 10% absolute mean relative error compared to clinician-determined optimal doses.
  • Morning dose suggestions were consistently lower than optimal, potentially due to differing dosing strategies or lack of morning on-off evaluations.

Conclusions:

  • The proposed algorithmic method shows promise for clinical application.
  • It can provide healthcare professionals with valuable supplementary information for dose adjustment decisions in Parkinson's disease management.